Related Experiment Video
Updated: Jan 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Residual Safety Margin-Based Risk Stratification for Hospital-Wide POCT Glucose Meters Anchored to ISO 15197: Moving
Hao Bi1, Yuting Chen1, Yihan Wu1
1Department of Laboratory Medicine, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China.
None:
Background: In this hospital-wide evaluation of point-of-care testing (POCT) glucose meters, we introduced a residual safety margin (r) anchored to ISO 15197:2013 thresholds to quantify tolerance, move beyond binary pass/fail assessments, and enable risk stratification. Methods: Thirty-five departmental glucose meters were compared with a central laboratory reference at five predefined glucose concentrations. Compliance was assessed using ISO 15197:2013 point-wise limits, Bland-Altman analysis was used to estimate bias and limits of agreement, and the mean absolute relative difference (MARD) and root mean square error (RMSE) were calculated to summarize overall error. At each concentration, r was calculated for every department, ranked, and classified into low, medium, or high risk using allowable error thresholds based on biological variation, specifically total allowable error (TEa), mapped to the ISO limits. Results: All departments met ISO criteria (100% compliance; 95% CI: 97.9-100%). Mean bias was -1.43 mg/dL, with limits of agreement from -15.6 to 12.8 mg/dL; MARD was 3.8% (95% CI: 3.4-4.3%), and RMSE was 7.4 mg/dL (95% CI: 6.6-8.2 mg/dL). Despite universal compliance, r-based analysis revealed concentration-related heterogeneity and highlighted borderline-performing departments that were overlooked by conventional metrics. Conclusions: By anchoring residual safety margins to ISO thresholds, the r framework shifts POCT glucose assessment from a binary pass/fail decision to a risk-stratified ranking approach, exposing latent performance variation and supporting targeted quality improvement at the hospital level.
More Related Videos
12:02Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
Published on: April 11, 2016
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Diabetes Mellitus: Type 2 and Gestational
Assessing Blood pressure in the Leg
Preparation: